Shitiz Sriwastava

1.9k total citations
60 papers, 728 citations indexed

About

Shitiz Sriwastava is a scholar working on Neurology, Pathology and Forensic Medicine and Infectious Diseases. According to data from OpenAlex, Shitiz Sriwastava has authored 60 papers receiving a total of 728 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Neurology, 22 papers in Pathology and Forensic Medicine and 14 papers in Infectious Diseases. Recurrent topics in Shitiz Sriwastava's work include Multiple Sclerosis Research Studies (18 papers), Peripheral Neuropathies and Disorders (15 papers) and Long-Term Effects of COVID-19 (15 papers). Shitiz Sriwastava is often cited by papers focused on Multiple Sclerosis Research Studies (18 papers), Peripheral Neuropathies and Disorders (15 papers) and Long-Term Effects of COVID-19 (15 papers). Shitiz Sriwastava collaborates with scholars based in United States, India and Nepal. Shitiz Sriwastava's co-authors include Medha Tandon, Saurabh Kataria, Erum Khan, Ashish Shrestha, Sijin Wen, Robert P. Lisak, Evanthia Bernitsas, Jenil Patel, Mihir Kakara and Sarah J. Peterson and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and American Journal of Roentgenology.

In The Last Decade

Shitiz Sriwastava

51 papers receiving 714 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shitiz Sriwastava United States 16 480 262 183 84 60 60 728
Sarah Laurent Germany 13 371 0.8× 120 0.5× 360 2.0× 133 1.6× 76 1.3× 19 828
Finja Schweitzer Germany 13 339 0.7× 166 0.6× 108 0.6× 58 0.7× 34 0.6× 27 591
Kévin Bigaut France 12 374 0.8× 337 1.3× 379 2.1× 119 1.4× 56 0.9× 28 671
Wendy Vargas United States 13 178 0.4× 140 0.5× 186 1.0× 43 0.5× 75 1.3× 35 498
David Magalashvili Israel 16 385 0.8× 441 1.7× 810 4.4× 150 1.8× 127 2.1× 48 1.1k
Yael Stern Israel 11 258 0.5× 170 0.6× 526 2.9× 57 0.7× 42 0.7× 15 679
Gülay Alper United States 19 729 1.5× 170 0.6× 677 3.7× 61 0.7× 244 4.1× 33 1.4k
Christa Walgaard Netherlands 15 1.8k 3.7× 172 0.7× 64 0.3× 26 0.3× 48 0.8× 21 2.0k
Enric Monreal Spain 9 271 0.6× 135 0.5× 115 0.6× 29 0.3× 20 0.3× 33 479
Michael Stone United Kingdom 8 964 2.0× 810 3.1× 43 0.2× 121 1.4× 57 0.9× 11 1.3k

Countries citing papers authored by Shitiz Sriwastava

Since Specialization
Citations

This map shows the geographic impact of Shitiz Sriwastava's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shitiz Sriwastava with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shitiz Sriwastava more than expected).

Fields of papers citing papers by Shitiz Sriwastava

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shitiz Sriwastava. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shitiz Sriwastava. The network helps show where Shitiz Sriwastava may publish in the future.

Co-authorship network of co-authors of Shitiz Sriwastava

This figure shows the co-authorship network connecting the top 25 collaborators of Shitiz Sriwastava. A scholar is included among the top collaborators of Shitiz Sriwastava based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shitiz Sriwastava. Shitiz Sriwastava is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sridhar, S., et al.. (2025). Diagnostic evolution in multiple sclerosis: A narrative review of the McDonald criteria from 2001 to 2024. Multiple Sclerosis and Related Disorders. 104. 106756–106756.
2.
Shrestha, Kriti, et al.. (2023). Late-onset Parry-Romberg Syndrome with atypical neurological manifestations: A case report. SHILAP Revista de lepidopterología. 19(1). 459–463.
3.
Sriwastava, Shitiz, et al.. (2023). Anti-CD20 monoclonal antibody (mAb) therapy and colitis: A case series and review. Multiple Sclerosis and Related Disorders. 75. 104763–104763. 10 indexed citations
4.
5.
Khan, Erum, et al.. (2022). Progressive Multifocal Leukoencephalopathy in immunocompetent a case report and review of literature (P12-12.002). Neurology. 98(18_supplement). 1 indexed citations
6.
7.
Casinelli, Gabriella, et al.. (2021). Breast Carcinoma After Ocrelizumab Therapy in Multiple Sclerosis Patients: A Case Series and Literature Review. SHILAP Revista de lepidopterología. 13. 2669565017–2669565017. 8 indexed citations
8.
Tandon, Medha, et al.. (2021). A Comprehensive Systematic Review of CSF analysis that defines Neurological Manifestations of COVID-19. International Journal of Infectious Diseases. 104. 390–397. 28 indexed citations
9.
Sriwastava, Shitiz, et al.. (2021). A rare case of gliomatosis cerebri lurking beneath the shadows of a stroke mimic. SHILAP Revista de lepidopterología. 16(9). 2701–2705. 1 indexed citations
10.
Khan, Erum, et al.. (2021). Acute transverse myelitis following SARS-CoV-2 vaccination: a case report and review of literature. Journal of Neurology. 269(3). 1121–1132. 63 indexed citations
11.
Tandon, Medha, et al.. (2021). Acute cerebellitis following SARS‐CoV‐2 infection: A case report and review of the literature. Journal of Medical Virology. 93(12). 6818–6821. 7 indexed citations
12.
Kataria, Saurabh, et al.. (2021). Acute transverse myelitis with Dysautonomia following SARS-CoV-2 infection: A case report and review of literature. Journal of Neuroimmunology. 353. 577523–577523. 32 indexed citations
13.
Sriwastava, Shitiz, et al.. (2021). Insight in booster COVID-19 vaccine and disease modifying therapy in multiple sclerosis. Journal of the Neurological Sciences. 430. 120034–120034. 3 indexed citations
14.
Kakara, Mihir, et al.. (2020). Characteristics of Patients with Anti-MAG Associated Neuropathy who Respond to Rituximab (5242). Neurology. 94(15_supplement). 1 indexed citations
15.
Kataria, Saurabh, et al.. (2020). A case series and literature review of multiple sclerosis and COVID-19: Clinical characteristics, outcomes and a brief review of immunotherapies. eNeurologicalSci. 21. 100287–100287. 19 indexed citations
16.
Bao, Fen, et al.. (2019). Characterizing Fatigue-Related White Matter Changes in MS: A Proton Magnetic Resonance Spectroscopy Study. Brain Sciences. 9(5). 122–122. 9 indexed citations
17.
18.
Sriwastava, Shitiz, et al.. (2019). Varicella zoster encephalitis in an immunocompromised patient presented with migraine type headache: A case report. eNeurologicalSci. 16. 100205–100205. 4 indexed citations
19.
Sriwastava, Shitiz, et al.. (2019). Neuroinvasive Spectrum of West Nile Virus. (P4.9-038). Neurology. 92(15_supplement). 1 indexed citations
20.
Sriwastava, Shitiz, Fen Bao, Evanthia Bernitsas, et al.. (2014). Long-term Safety of Rituximab and Peripheral B-Cell Depletion in Multiple Sclerosis and Other CNS Autoimmune Disorders (P2.223). Neurology. 82(10_supplement). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sarah Laurent Breakdown of academic impact, for papers by Finja Schweitzer Breakdown of academic impact, for papers by Kévin Bigaut Breakdown of academic impact, for papers by Wendy Vargas Breakdown of academic impact, for papers by David Magalashvili Breakdown of academic impact, for papers by Yael Stern Breakdown of academic impact, for papers by Gülay Alper Breakdown of academic impact, for papers by Christa Walgaard Breakdown of academic impact, for papers by Enric Monreal Breakdown of academic impact, for papers by Michael Stone
Rankless by CCL
2026